Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
An export-only exception to pharmaceutical patents in Europe: should the United States follow suit?
Home
Publications
An export-only exception to pharmaceutical patents in Europe: should the United States follow suit?
An export-only exception to pharmaceutical patents in Europe: should the United States follow suit?
Authors:
Timo Minssen
Timo Minssen
AK
Aaron S Kesselheim
Aaron S Kesselheim
Jonathan J Darrow
Jonathan J Darrow
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
3 January 2019
journal article
editorial
Published by
Springer Nature
in
Nature Biotechnology
Vol. 37
(1)
,
21-22
DOI:
10.1038/nbt.4324
PMID:
30605154
Abstract
No abstract available
Keywords
UNITED STATES
STATES FOLLOW
FOLLOW SUIT
EXPORT-ONLY EXCEPTION
PHARMACEUTICAL PATENTS
EUROPEAN UNION
EUROPE
UNITED
STATES
UNION POLICY
Cited
Cited by 3 articles
Scroll to top